Indication
Yellow Fever Vaccination
1 clinical trial
4 products
Clinical trial
A Phase I, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA 720 Adjuvant in 18-45 Year Old Healthy AdultsStatus: Completed, Estimated PCD: 2018-03-22
Product
ISA-720Product
MVA Smallpox VaccineProduct
MVA-BN Yellow Fever VaccineProduct
YF Vax 17D Strain